BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
+0.86%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$139M
AUM Growth
+$139M
(-10%)
Cap. Flow
-$1.79M
Cap. Flow
% of AUM
-1.29%
Top 10 Holdings %
Top 10 Hldgs %
71.95%
Holding
68
New
1
Increased
14
Reduced
5
Closed
5
Top Buys
| 1 |
DocGo
DCGO
|
$925K |
| 2 |
Soleno Therapeutics
SLNO
|
$624K |
| 3 |
Phreesia
PHR
|
$264K |
| 4 |
Gossamer Bio
GOSS
|
$252K |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$237K |
Top Sells
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$2.05M |
| 2 |
Bristol-Myers Squibb
BMY
|
$876K |
| 3 |
Progyny
PGNY
|
$755K |
| 4 |
Biogen
BIIB
|
$526K |
| 5 |
Foghorn Therapeutics
FHTX
|
$305K |
Sector Composition
| 1 | Healthcare | 94.92% |
| 2 | Energy | 2.82% |
| 3 | Consumer Staples | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$96B
| $55.1M | 39.65% | 754,106 -12,000 | -2% | -$876K |
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $8.37M | 6.02% | 89,240 +40 | +0% | +$3.75K |
|
3
Elutia
ELUT
$96.7M
| $8.28M | 5.96% | 1,417,923 | – | – |
|
4
QuidelOrtho
QDEL
$1.95B
| $6.71M | 4.83% | 59,684 | – | – |
|
5
Acadia Pharmaceuticals
ACAD
$4.38B
| $4.83M | 3.48% | 199,400 | – | – |
|
|
6
Foghorn Therapeutics
FHTX
$286M
| $4.48M | 3.23% | 294,143 -20,000 | -6% | -$305K |
|
|
ALBO
7
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $3.37M | 2.43% | 113,000 | – | – |
|
|
AXDX
8
DELISTED
Accelerate Diagnostics
AXDX
| $3.24M | 2.33% | 2,252,388 | – | – |
|
9
United Therapeutics
UTHR
$13.8B
| $3.23M | 2.32% | 18,000 | – | – |
|
|
CLR
10
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $2.37M | 1.7% | 38,600 | – | – |
|
|
11
Biogen
BIIB
$19.4B
| $2.13M | 1.53% | 10,100 -2,500 | -20% | -$526K |
|
12
Biodesix
BDSX
$62.6M
| $2.12M | 1.52% | 1,252,753 | – | – |
|
13
Karyopharm Therapeutics
KPTI
$61.7M
| $1.99M | 1.43% | 269,332 +23,332 | +9% | +$172K |
|
14
Ovintiv
OVV
$10.8B
| $1.85M | 1.33% | 34,200 | – | – |
|
|
BHVN
15
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.66M | 1.2% | 14,000 +2,000 | +17% | +$237K |
|
16
Prothena Corp
PRTA
$441M
| $1.54M | 1.11% | 41,978 +1,731 | +4% | +$63.3K |
|
17
Masimo
MASI
$7.59B
| $1.35M | 0.97% | 9,280 +1,280 | +16% | +$186K |
|
18
Alkermes
ALKS
$4.78B
| $1.32M | 0.95% | 50,000 | – | – |
|
19
Harrow
HROW
$1.44B
| $1.23M | 0.88% | 180,000 | – | – |
|
20
Corcept Therapeutics
CORT
$7.35B
| $1.13M | 0.81% | 50,000 | – | – |
|
|
INBX
21
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.12M | 0.81% | 50,448 +10,448 | +26% | +$233K |
|
|
ETRN
22
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $1.12M | 0.81% | 133,050 | – | – |
|
|
23
Gossamer Bio
GOSS
$562M
| $1.12M | 0.81% | 129,088 +29,088 | +29% | +$252K |
|
|
24
DocGo
DCGO
$153M
| $1.02M | 0.73% | 110,000 +100,000 | +1,000% | +$925K |
|
25
Arvinas
ARVN
$568M
| $1.01M | 0.73% | 15,000 | – | – |
|